PURCHASE ORDER

MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026

Awarded to MCKESSON CORPORATION

PIID 15B30727P00000004US · USAspendingBiotechnology & Pharmaceuticals
$2K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$2,000sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateOct 1, 2026
Company legal name
MCKESSON CORPORATION
UEI / CAGE
S1RUKWWRYFL6 / Not reported
Parent award
Not reported
Awarding agency
Department of Justice
Subagency
Federal Prison System / Bureau of Prisons
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
6555 STATE HIGHWAY 161, IRVING, DALLAS, TX, 75039
Place of performance
IRVING, DALLAS, TX, 75039
Source last modified
Oct 28, 2026

Description

MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026

    US · usaspendingSource ↗
  2. Value increased

    MCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026

    US · usaspending$2KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Oct 19, 20260Not reported$2,000.00Not reportedNot reportedMCKESSON OPEN MARKET Q1 MEDICATION FY27 MEDICATION FOR INMATE POPULATION CR - HR 6500 EXP 12.11.2026USAspending ↗